The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of SMARCB1 deficiency in renal medullary carcinoma (RMC) on genes associated with nucleosome assembly and telomere organization.
 
Pavlos Msaouel
No Relationships to Disclose
 
Gabriel G. Malouf
Honoraria - GlaxoSmithKline; Janssen; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Janssen; Novartis; Pfizer
 
Xiaoping Su
No Relationships to Disclose
 
Hui Yao
No Relationships to Disclose
 
Durga N Tripathi
No Relationships to Disclose
 
Jianjun Gao
Travel, Accommodations, Expenses - AstraZeneca
 
Priya Rao
No Relationships to Disclose
 
Rong He
No Relationships to Disclose
 
Jose A. Karam
Honoraria - EMD Serono; Novartis; Pfizer
Consulting or Advisory Role - EMD Serono; Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Christopher G. Wood
Honoraria - Pfizer
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Argos Therapeutics; Boehringer Ingelheim; GlaxoSmithKline; Ono Pharmaceutical; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics
 
Cheryl Lyn Walker
No Relationships to Disclose
 
Nizar M. Tannir
Honoraria - Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Epizyme; Exelixis; Mirati Therapeutics; Novartis
Travel, Accommodations, Expenses - Argos Therapeutics; Argos Therapeutics; Bristol-Myers Squibb; Calithera Biosciences; Exelixis; Nektar; Novartis; Pfizer